MA
BPMC

MUFG Americas’s Blueprint Medicines BPMC Stock Holding History

MUFG Americas’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-150
Closed -$10K – 751
2018
Q2 		$10K Hold
150
– – ﹤0.01% 774
2018
Q1 		$14K Sell
150
-55
-27% -$4.74K ﹤0.01% 716
2017
Q4 		$15K Buy
205
+120
+141% +$8.44K ﹤0.01% 804
2017
Q3 		$6K Hold
85
– – ﹤0.01% 919
2017
Q2 		$4K Buy
+85
New +$3.61K ﹤0.01% 951

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

MUFG Americas's BPMC Position: Q3 2018 in Review

MUFG Americas sold out of Blueprint Medicines (BPMC) in Q3 2018, closing a stake of 150 shares — an estimated $10K sold.

MUFG Americas first reported a position in BPMC in Q2 2017 and held it in 5 quarters. The position peaked at $15K in Q4 2017. 188 funds tracked by Wall St. Rank hold BPMC as of Q3 2018.

  • MUFG Americas reported no remaining Blueprint Medicines position as of Q3 2018 after selling out during the quarter.
  • MUFG Americas sold 150 Blueprint Medicines shares in Q3 2018, an estimated $10K.
  • MUFG Americas first reported a position in Blueprint Medicines in Q2 2017 and held it in 5 quarters.
  • MUFG Americas's Blueprint Medicines position peaked at $15K in Q4 2017.
  • 188 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2018.

Based on MUFG Americas's 13F filing for Q3 2018, filed 14 Nov 2018.